127 related articles for article (PubMed ID: 24686425)
1. Polyomavirus BK viremia in kidney transplant recipients after desensitization with IVIG and rituximab.
Barbosa D; Kahwaji J; Puliyanda D; Mirocha J; Reinsmoen N; Lai CH; Villicana R; Peng A; Jordan SC; Vo A; Toyoda M
Transplantation; 2014 Apr; 97(7):755-61. PubMed ID: 24686425
[TBL] [Abstract][Full Text] [Related]
2. Evaluating the impact of pre-transplant desensitization utilizing a plasmapheresis and low-dose intravenous immunoglobulin protocol on BK viremia in renal transplant recipients.
Gabardi S; Townsend K; Martin ST; Chandraker A
Transpl Infect Dis; 2013 Aug; 15(4):361-8. PubMed ID: 23647907
[TBL] [Abstract][Full Text] [Related]
3. Impact of Desensitization on Antiviral Immunity in HLA-Sensitized Kidney Transplant Recipients.
Toyoda M; Shin BH; Ge S; Mirocha J; Thomas D; Chu M; Rodriguez E; Chao C; Petrosyan A; Galera OA; Vo A; Choi J; Peng A; Kahwaji J; Jordan SC
J Immunol Res; 2017; 2017():5672523. PubMed ID: 28265581
[TBL] [Abstract][Full Text] [Related]
4. JC polyomavirus viremia and progressive multifocal leukoencephalopathy in human leukocyte antigen-sensitized kidney transplant recipients desensitized with intravenous immunoglobulin and rituximab.
Toyoda M; Thomas D; Ahn G; Kahwaji J; Mirocha J; Chu M; Vo A; Suviolahti E; Ge S; Jordan SC
Transpl Infect Dis; 2015 Dec; 17(6):838-47. PubMed ID: 26437369
[TBL] [Abstract][Full Text] [Related]
5. Everolimus leads to a lower risk of BKV viremia than mycophenolic acid in de novo renal transplantation patients: a single-center experience.
Moscarelli L; Caroti L; Antognoli G; Zanazzi M; Di Maria L; Carta P; Minetti E
Clin Transplant; 2013; 27(4):546-54. PubMed ID: 23758330
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of intravenous immunoglobulin in the treatment of persistent BK viremia and BK virus nephropathy in renal transplant recipients.
Vu D; Shah T; Ansari J; Naraghi R; Min D
Transplant Proc; 2015 Mar; 47(2):394-8. PubMed ID: 25769580
[TBL] [Abstract][Full Text] [Related]
7. Ciprofloxacin prophylaxis in kidney transplant recipients reduces BK virus infection at 3 months but not at 1 year.
Wojciechowski D; Chanda R; Chandran S; Lee B; Webber A; Macaraig M; Tomlanovich S; Vincenti F
Transplantation; 2012 Dec; 94(11):1117-23. PubMed ID: 23060281
[TBL] [Abstract][Full Text] [Related]
8. Intravenous immunoglobulin as a preventive strategy against BK virus viremia and BKV-associated nephropathy in kidney transplant recipients-Results from a proof-of-concept study.
Benotmane I; Solis M; Velay A; Cognard N; Olagne J; Gautier Vargas G; Perrin P; Marx D; Soulier E; Gallais F; Moulin B; Fafi-Kremer S; Caillard S
Am J Transplant; 2021 Jan; 21(1):329-337. PubMed ID: 32741096
[TBL] [Abstract][Full Text] [Related]
9. Isolated heart and liver transplant recipients are at low risk for polyomavirus BKV nephropathy.
Puliyanda DP; Amet N; Dhawan A; Hilo L; Radha RK; Bunnapradist S; Czer L; Martin P; Jordan S; Toyoda M
Clin Transplant; 2006; 20(3):289-94. PubMed ID: 16824143
[TBL] [Abstract][Full Text] [Related]
10. Reactivation of BK Virus in the Early Period After Kidney Transplantation.
Ziedina I; Folkmane I; Chapenko S; Murovska M; Sultanova A; Jushinskis J; Rozental R
Transplant Proc; 2009 Mar; 41(2):766-8. PubMed ID: 19328975
[TBL] [Abstract][Full Text] [Related]
11. Prospective monitoring of BK virus replication in renal transplant recipients.
Koukoulaki M; Grispou E; Pistolas D; Balaska K; Apostolou T; Anagnostopoulou M; Tseleni-Kotsovili A; Hadjiconstantinou V; Paniara O; Saroglou G; Legakis N; Drakopoulos S
Transpl Infect Dis; 2009 Feb; 11(1):1-10. PubMed ID: 18811631
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and risk factors of polyomavirus BK replication in simultaneous pancreas/kidney transplant recipients from a single transplant center.
Mindlova M; Boucek P; Saudek F; Skibova J; Jedinakova T; Lipar K; Adamec M; Hirsch HH
Clin Transplant; 2012; 26(2):267-74. PubMed ID: 21854452
[TBL] [Abstract][Full Text] [Related]
13. Intravenous immunoglobulin therapy in the treatment of BK viremia and nephropathy in pediatric renal transplant recipients.
Anyaegbu EI; Almond PS; Milligan T; Allen WR; Gharaybeh S; Al-Akash SI
Pediatr Transplant; 2012 Feb; 16(1):E19-24. PubMed ID: 22248251
[TBL] [Abstract][Full Text] [Related]
14. Efficacy, outcomes, and cost-effectiveness of desensitization using IVIG and rituximab.
Vo AA; Petrozzino J; Yeung K; Sinha A; Kahwaji J; Peng A; Villicana R; Mackowiak J; Jordan SC
Transplantation; 2013 Mar; 95(6):852-8. PubMed ID: 23511212
[TBL] [Abstract][Full Text] [Related]
15. BK virus (BKV) plasma dynamics in patients with BKV-associated hemorrhagic cystitis following allogeneic stem cell transplantation.
Drew RJ; Walsh A; Ní Laoi B; Conneally E; Crowley B
Transpl Infect Dis; 2013 Jun; 15(3):276-82. PubMed ID: 23473059
[TBL] [Abstract][Full Text] [Related]
16. Polyomavirus BK versus JC replication and nephropathy in renal transplant recipients: a prospective evaluation.
Drachenberg CB; Hirsch HH; Papadimitriou JC; Gosert R; Wali RK; Munivenkatappa R; Nogueira J; Cangro CB; Haririan A; Mendley S; Ramos E
Transplantation; 2007 Aug; 84(3):323-30. PubMed ID: 17700156
[TBL] [Abstract][Full Text] [Related]
17. Dual positivity of donor and recipient plasma for BK virus confers a high risk for development of bk nephropathy in renal allograft.
Thakur R; Joshi K; Minz M; Singla A; Nada R; Arora S; Jha V; Sakhuja V
Transplant Proc; 2012 Apr; 44(3):717-20. PubMed ID: 22483476
[TBL] [Abstract][Full Text] [Related]
18. Risk for BK viremia and nephropathy after desensitization.
Sharif A; Racusen L; Montgomery R; Kraus E
Transplantation; 2014 Jul; 98(2):e7-8. PubMed ID: 25022238
[No Abstract] [Full Text] [Related]
19. Sustained BK viruria as an early marker for the development of BKV-associated nephropathy: analysis of 4128 urine and serum samples.
Babel N; Fendt J; Karaivanov S; Bold G; Arnold S; Sefrin A; Lieske E; Hoffzimmer M; Dziubianau M; Bethke N; Meisel C; Grütz G; Reinke P
Transplantation; 2009 Jul; 88(1):89-95. PubMed ID: 19584686
[TBL] [Abstract][Full Text] [Related]
20. CMV Viremia is associated with a decreased incidence of BKV reactivation after kidney and kidney-pancreas transplantation.
Elfadawy N; Flechner SM; Liu X; Schold J; Srinivas TR; Poggio E; Fatica R; Avery R; Mossad SB
Transplantation; 2013 Dec; 96(12):1097-103. PubMed ID: 24056621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
